Sterile Injectable CDMOs

CMP Phar.ma Srl

Italy

CMP Phar.ma Srl is an Italian manufacturer of inspection and leak test machines for pharmaceutical parenteral products, operating since 1969. The company produces optical inspection benches, semi-automatic and fully automatic inspection machines, and leak test systems for ampoules, vials, cartridges, and prefilled syringes, with ISO 9001 certification since 2008. CMP Phar.ma is part of the Marchesini Group.

NEXUS COMPANY INC

Japan

NEXUS COMPANY INC is a Kyoto, Japan-based manufacturer of quartz glass vials, test tubes, and screw-neck containers for pharmaceutical, laboratory, and analytical applications. The company produces the world's first mass-produced quartz vials (SiO2 99.99% fused quartz) with properties including non-alkali elution, high heat resistance, and UV transmittance. Note: This is distinct from Nexus Pharmaceuticals (US), which is a sterile injectable CDMO.

Recce Pharmaceuticals

Australia

Recce Pharmaceuticals (ASX:RCE) is a clinical-stage biotech company developing its own proprietary synthetic anti-infectives (RECCE 327, RECCE 529) for antibiotic-resistant bacterial and viral infections. They have an in-house pilot manufacturing facility in Macquarie Park, Sydney for their own compounds only -- they are NOT a contract manufacturer (CDMO/CMO). They conduct clinical trials (Phase I-III) for their own drug pipeline. The FDA registration data and approved products listed in the regulatory summary likely belong to a different entity sharing the FEI numbers, not this clinical-stage company.

Shandong Luoxin Pharmaceutical Group

China

Shandong Luoxin Pharmaceutical Group is a Chinese publicly listed pharmaceutical company (Stock Code: 002793) that develops, manufactures, and commercializes its own branded pharmaceutical products. The company signs licensing agreements with international partners (Marinomed, JW Holdings, HK inno.N) for in-licensing drugs into the Chinese market. While it has 4 FDA-registered manufacturing sites with FDA-approved injectable products, it operates as a branded pharma company rather than a contract manufacturer.

Upsher-Smith Laboratories

United States

Upsher-Smith Laboratories is a U.S. pharmaceutical company (now a subsidiary of Bora Pharmaceuticals following a $210 million acquisition in April 2024) that manufactures and markets brand and generic pharmaceutical products. It has a 270,000 sq ft manufacturing facility in Plymouth/Maple Grove, Minnesota. Key products include branded medications for migraine and seizure disorders plus a wide variety of generics (48 products). In December 2025 it launched KYMBEE (deflazacort) for Duchenne muscular dystrophy. While Bora Pharmaceuticals is a CDMO, Upsher-Smith itself manufactures and markets its own branded/generic portfolio rather than providing contract manufacturing services to third parties.

Jiangsu Hengrui Medicine Co., Ltd. is China's largest listed pharmaceutical company, founded in 1970, with over 20,000 employees globally. Hengrui is primarily an innovation-driven pharma company developing and manufacturing its own drugs across oncology, cardiovascular, metabolism, autoimmune, pain, and anti-infection therapeutic areas, with a pipeline of 257 drugs and 24 Class 1 innovative drugs. While it has some CDMO references in search results, Perplexity research confirms it primarily specializes in proprietary drug development and manufacturing rather than contract services.

Spectrum Chemical Manufacturing Corp, headquartered in New Brunswick, New Jersey, is an FDA-registered supplier of high-purity chemicals, APIs, excipients, fine chemicals, intermediates, nutrients for formulated media, and cGMP chemicals for biopharmaceutical and life science industries. They offer over 45,000 chemicals including the largest catalog of 1,200 USP-NF-FCC items, with bicoastal manufacturing facilities in New Jersey and California. While listed on CDMO directories, Spectrum's core business is manufacturing and distributing chemical raw materials and lab supplies rather than contract drug product manufacturing for other companies.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is one of the world's largest specialty generic pharmaceutical companies, headquartered in Mumbai, India. While the company has massive manufacturing operations (1,075 FDA-approved products, 25+ FDA-registered FEI numbers), it primarily manufactures and markets its own branded and generic pharmaceutical products rather than providing contract manufacturing services to third parties as a CDMO.

Antares Vision Group is an Italian technology company providing inspection systems, track-and-trace serialization, and smart data management solutions for life science, food, beverage, and cosmetics industries. They supply equipment and software for pharma production lines but do not manufacture drugs.

DHL is a global logistics and shipping company providing international express delivery, freight forwarding, supply chain solutions, and warehousing services. While DHL serves the pharmaceutical industry as a logistics and cold-chain partner, it does not manufacture drugs or provide pharmaceutical development services.

Hoffmann Neopac AG is a leading packaging manufacturer of Polyfoil, PE, and COEX tubes for pharmaceutical, cosmetics, and dental industries with over 100 years of history. The company operates production sites in Switzerland (450 million tubes/year), Hungary, the US, and India, with combined global capacity exceeding 1 billion tubes per year. Neopac is ISO 15378 (pharmaceutical packaging) certified but does not manufacture drugs.

Yung Shin Pharmaceutical Industrial Co., Ltd. (YSP) is a Taiwanese pharmaceutical company founded in 1952, manufacturing prescription medications, OTC medicines, health food, and cosmetics. The company exports to 35+ countries and has passed US FDA and Japan PMDA inspections. Primarily manufactures and markets its own branded pharmaceutical products.